1. Home
  2. CVAC vs MBWM Comparison

CVAC vs MBWM Comparison

Compare CVAC & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • MBWM
  • Stock Information
  • Founded
  • CVAC 2000
  • MBWM 1997
  • Country
  • CVAC Germany
  • MBWM United States
  • Employees
  • CVAC N/A
  • MBWM N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • MBWM Major Banks
  • Sector
  • CVAC Health Care
  • MBWM Finance
  • Exchange
  • CVAC Nasdaq
  • MBWM Nasdaq
  • Market Cap
  • CVAC 818.8M
  • MBWM 732.4M
  • IPO Year
  • CVAC 2020
  • MBWM 1997
  • Fundamental
  • Price
  • CVAC $3.12
  • MBWM $40.68
  • Analyst Decision
  • CVAC Buy
  • MBWM Buy
  • Analyst Count
  • CVAC 2
  • MBWM 2
  • Target Price
  • CVAC $10.00
  • MBWM $55.00
  • AVG Volume (30 Days)
  • CVAC 717.4K
  • MBWM 66.3K
  • Earning Date
  • CVAC 04-10-2025
  • MBWM 04-22-2025
  • Dividend Yield
  • CVAC N/A
  • MBWM 3.55%
  • EPS Growth
  • CVAC N/A
  • MBWM N/A
  • EPS
  • CVAC 0.75
  • MBWM 4.93
  • Revenue
  • CVAC $554,073,921.00
  • MBWM $224,075,000.00
  • Revenue This Year
  • CVAC N/A
  • MBWM $7.91
  • Revenue Next Year
  • CVAC $66.34
  • MBWM $4.22
  • P/E Ratio
  • CVAC $4.19
  • MBWM $8.25
  • Revenue Growth
  • CVAC 895.54
  • MBWM 2.79
  • 52 Week Low
  • CVAC $2.22
  • MBWM $33.46
  • 52 Week High
  • CVAC $5.28
  • MBWM $52.98
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 53.48
  • MBWM 42.67
  • Support Level
  • CVAC $3.05
  • MBWM $37.76
  • Resistance Level
  • CVAC $3.02
  • MBWM $42.27
  • Average True Range (ATR)
  • CVAC 0.19
  • MBWM 2.02
  • MACD
  • CVAC 0.06
  • MBWM 0.05
  • Stochastic Oscillator
  • CVAC 79.14
  • MBWM 45.91

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It provides a variety of commercial banking services to individuals, businesses, governmental units, and other institutions. It provides banking services offering deposit products including checking, savings, and term certificate accounts, and lending products including commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

Share on Social Networks: